Table: begin end state 1 11 cytoplasmic 12 31 transmembrane 32 36 non-cytoplasmic 37 56 transmembrane 57 65 cytoplasmic 66 85 transmembrane 86 111 non-cytoplasmic 112 138 transmembrane 139 147 cytoplasmic 148 167 transmembrane 168 186 non-cytoplasmic 187 207 transmembrane 208 237 cytoplasmic 238 258 transmembrane 259 269 non-cytoplasmic 270 291 transmembrane 292 310 cytoplasmic 311 332 transmembrane 333 352 non-cytoplasmic 353 386 transmembrane 387 395 cytoplasmic 396 419 transmembrane 420 433 non-cytoplasmic 434 456 transmembrane 457 457 cytoplasmic
Input: >N515DRAFT_2225 FitnessBrowser__Dyella79:N515DRAFT_2225 MNPIQTNFLLQGDALLLAAALAVVVLIYLIAALKLNPFVALLMVSLGLGVAVGMPMKGIV KAFETGAGGTLGHIALLIALGTMLGKMMAESGGTERIAHTLIAAFGERRAHWAMMTVAFI VGLPVFFDVGFVLLVPVAFHIAKRAGMPLLLIGLSMSAGLSVVHGLVPPHPAALLAVTAY QADIGKTILYAVLIGLPTAIIAGPLFARWVTRYVTVEAENPLEKEFVEIDQERQLPSFGI ALATLLLPVLLMLVGTWADLLSTPGSRANAVLGFLGNPVVALLVAVLLSFYTFGKRRGFS RETILGFTNDCLAPTATVILVVGAGGGFGRILLDSGVSHAIIGATQSSQISPLLLGWLIA ALLRIATGSATVAMGTACGIVAPIAAAASKAVHPELMVLATGAGSLILSHVNDGGFWIVK QYFNMTVTQTLKTWTVLETIISVVALLLTLGLAAVLG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server